Cardiomyopathy
151
22
23
90
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
29 trials with published results (19%)
Research Maturity
90 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.3%
11 terminated out of 151 trials
89.1%
+2.6% vs benchmark
13%
19 trials in Phase 3/4
32%
29 of 90 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 90 completed trials
Clinical Trials (151)
ATR 1072 in Participants With PRKAG2 Syndrome
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
Clinical Course Of Disease In Participants With FA-CM
PET/CT Imaging in Carriers of TTR Mutations
AIC Genotyping Study
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
Pediatric Lead Extractability and Survival Evaluation (PLEASE)
French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry